Home / Investors / 2018 in Review / We are doing even more

We are doing even more


Our latest solutions run the gamut from better access to prescriptions to innovative treatment of chronic kidney disease, diabetes, and rheumatoid arthritis.

With the 2018 launch of same-day delivery in six cities, we’ve made it easier than ever for CVS Pharmacy customers to receive their prescriptions. Using the CVS app, customers can arrange for delivery within three hours and can include vitamins and other select non-prescription items with their orders as well. We expect our same-day delivery program to grow substantially in 2019.

Chronic kidney disease costs Medicare $100 billion annually. Despite this high level of spending, Medicare patients treated with traditional in-center hemodialysis suffer mortality rates up to 10 times higher than among the general Medicare population. Through a new CVS Health initiative that includes early identification of the disease, patient education, and an expansion of home dialysis, we are working to redefine kidney care. Our unique enterprise assets—Coram, CVS Specialty®, and Accordant® among them—​create a unique value proposition. Moreover, we have developed groundbreaking technology, set for a clinical trial later this year, that is designed to make home-based hemodialysis simple and safe for patients to facilitate longer, more frequent treatments. Based on clinical research, this approach improves quality of life, reduces hospital stays and readmissions, and lowers mortality by 45 percent.

Our Transform Care® programs help plan members manage chronic conditions effectively by drawing on our full range of assets and identifying personalized improvement opportunities. For example, Transform Diabetes Care® lowers pharmacy costs through aggressive trend management and decreases medical costs by improving medication adherence, A1C control, and lifestyle management. Transform Rheumatoid Arthritis CareTM, which leverages our specialty pharmacy and embedded AccordantCareTM nurses, is helping clients better manage care and costs for this complex autoimmune disorder.


More than


Americans are on dialysis


$100 billion

annual Medicare total cost of care for chronic kidney disease/end-stage renal disease


Members enrolled in Transform Diabetes Care have seen a

1 point improvement

in their A1C levels maintained over 12 months



of members with uncontrolled diabetes were moved to controlled status

Jon Roberts

“For people with mobility issues or those with busy lifestyles who can’t easily get to the pharmacy, home prescription delivery is a game changer. By extending care right to a patient’s doorstep, we make it easier for patients to get on, and stay on, their prescribed therapies.”
Jonathan C. Roberts
Executive Vice President and Chief Operating Officer